Our clinical investigation showed that CD63 expression was frequently down‐regulated in HCC tissues, and reduced CD63 expression was associated with larger tumour size, distant site metastasis and higher TNM stages. The gene discussed is CD63; the disease is hepatocellular carcinoma.